Dow Up 0.12% Nasdaq Up 1.35%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
22.67 0.09(0.40%) Oct 20, 4:00PM EDT
Prev Close:22.76
Open:22.69
Bid:22.63 x 400
Ask:22.67 x 1000
1y Target Est:38.17
Beta:0.89
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:22.41 - 23.05
52wk Range:18.97 - 32.98
Volume:192,265
Avg Vol (3m):140,123
Market Cap:466.93M
P/E (ttm):25.19
EPS (ttm):0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXDown 0.40%466.93M
ALXN33.27B
CPIX86.83M
SLXP9.04B

Key Statistics

Forward P/E (1 yr):377.83
P/S (ttm):5.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.54
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback